A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 50, 2006, Pages 19164-19169

  Kim, Chun Hyung ^a   Hahn, Maureen K ^b   Joung, Yoosook ^c   Anderson, Susan L ^a   Steele, Angela H ^b   Mazei Robinson, Michelle S ^b   Gizer, Ian ^d   Teicher, Martin H ^a   Cohen, Bruce M ^a   Robertson, David ^e   Waldman, Irwin D ^d   Blakely, Randy D ^b   Kim, Kwang Soo ^a  

^a MCLEAN HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d EMORY UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

E2 box; Scratch; Slug; Snail family

Indexed keywords

BINDING PROTEIN; CARRIER PROTEIN; GENE PRODUCT; GLYCOPROTEIN E2; NORADRENALIN; NORADRENALIN TRANSPORTER; PALINDROMIC DNA; SCRATCH PROTEIN; SOLUTE CARRIER FAMILY 6 MEMBER 2; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG; DNA; SLC6A2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE ACTIVITY; GENE CONSTRUCT; GENE FUNCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; NEUROTRANSMISSION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN BINDING;

GASTROPODA;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASE SEQUENCE; DNA; GENE EXPRESSION REGULATION; HUMANS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ZINC FINGERS;

EID: 33947264596     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0510836103     Document Type: Article

References (33)

1. Iversen LL (1963) Br J Pharmacol Chemother 21:523-537.
2. Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG (2000) Nat Neurosci 3:465-471.
3. Keller NR, Diedrich A, Appalsamy M, Tuntrakool S, Lonce S, Finney C, Caron MG, Robertson D (2004) Circulation 110:1191-1196.
4. Amara SG, Kuhar MJ (1993) Annu Rev Neurosci 16:73-93.
5. Bruss M, Kunz J, Lingen B, Bonisch H (1993) Hum Genet 91:278-280.
6. Pacholczyk T, Blakely RD, Amara SG (1991) Nature 350:350-354.
7. Marien MR, Colpaert FC, Rosenquist AC (2004) Brain Res Brain Res Rev 45:38-78.
8. Beane M, Marrocco RT (2004) Prog Neurobiol 74:167-181.
9. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA (1997) J Neurosci 17:8451-8458.
10. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997) J Pharmacol Exp Ther 283:1305-1322.
11. Biederman J, Heiligenstein JH, Faries DE, Galil N, Dittmann R, Emslie GJ, Kratochvil CJ, Laws HF, Schuh KJ (2002) Pediatrics 110:e75.
12. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) N Engl J Med 342:541-549.
13. Urwin RE, Bennetts B, Wilcken B, Lampropoulos B, Beumont P, Clarke S, Russell J, Tanner S, Nunn KP (2002) Mol Psychiatry 7:652-657.
14. De Luca V, Muglia P, Jain U, Kennedy JL (2004) Am J Med Genet B Neuropsychiatr Genet 124:38-40.
15. McEvoy B, Hawi Z, Fitzgerald M, Gill M (2002) Am J Med Genet 114:665-666.
16. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, Clasen LS, Sharp WS, Inoff-Germain G, Wavrant-De Vrieze F, et al. (2005) Am J Med Genet B Neuropsychiatr Genet 134:67-72.
17. Xu X, Knight J, Brookes K, Mill J, Sham P, Craig I, Taylor E, Asherson P (2005) Am J Med Genet B Neuropsychiatr Genet 134:115-118.
18. Cook EH, Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995) Am J Hum Genet 56:993-998.
19. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C (1998) Am J Hum Genet 63:1767-1776.
20. Kim CH, Hwang DY, Park JJ, Kim KS (2002) J Neurosci 22:2579-2589.
21. Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, Robertson D, Kim KS (2002) Am J Med Genet 108:140-147.
22. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, et al. (1998) Nucleic Acids Res 26:362-367.
23. Funahashi J, Sekido R, Murai K, Kamachi Y, Kondoh H (1993) Development (Cambridge, UK) 119:433-446.
24. Nieto MA (2002) Nat Rev Mol Cell Biol 3:155-166.
25. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (Am Psychiatric Assoc, Washington, DC), 4th Ed.
26. Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F, Kranzler HR, Ichinose H, Gelernter J (1997) Am J Med Genet 74:374-379.
27. Lander ES, Schork NJ (1994) Science 265:2037-2048.
28. International HapMap Consortium (2005) Nature 437:1299-1320.
29. Stober G, Hebebrand J, Cichon S, Bruss M, Bonisch H, Lehmkuhl G, Poustka F, Schmidt M, Remschmidt H, Propping P, Nothen MM (1999) Am J Med Genet 88:158-163.
30. Hahn MK, Blakely RD (2002) Pharmacogenomics J 2:217-235.
31. Marin F, Nieto MA (2006) Dev Dyn 235:2586-2591.
32. Ambrosini PJ (2000) J Am Acad Child Adolesc Psychiatry 39:49-58.
33. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) J Am Acad Child Adolesc Psychiatry 36:980-988.